SCOPUS 정보 검색 플랫폼 - 논문 보기

메뉴 건너뛰기

Journal of Preventive Medicine and Public Health

Volumn 40, Issue 4, 2007, Pages 278-284

Adverse drug reaction surveillance system in Korea

(2) Choi, Nam Kyong a Park, Byung Joo a

a Seoul National University College of Medicine (South Korea)

Author keywords

Adverse drug reaction reporting systems; Data mining; Drug toxicity; Postmarketing; Product surveillance

Indexed keywords

DRUG SURVEILLANCE PROGRAM; HUMAN; INFORMATION SYSTEM; KOREA; MEDICAL INFORMATICS; ORGANIZATION AND MANAGEMENT; POSTMARKETING SURVEILLANCE; REVIEW;

ADVERSE DRUG REACTION REPORTING SYSTEMS; HUMANS; INFORMATION SYSTEMS; KOREA; PRODUCT SURVEILLANCE, POSTMARKETING; PUBLIC HEALTH INFORMATICS;

EID: 34548563976 PISSN: 19758375 EISSN: None Source Type: Journal
DOI: 10.3961/jpmph.2007.40.4.278 Document Type: Article

Times cited : (24)

References (9)

1
- 0032522873
- Incidence of adverse drug reactions in hospitalized patients: A meta- analysis of prospective studies
- DOI 10.1001/jama.279.15.1200
- Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279(15): 1200-1205 (Pubitemid 28193431)
- (1998) Journal of the American Medical Association , vol.279 , Issue.15 , pp. 1200-1205
- Lazarou, J.¹ Pomeranz, B.H.² Corey, P.N.³

2
- 0034949062
- Identifying hospital admissions due to adverse drug events using a computer-based monitor
- DOI 10.1002/pds.568
- Jha AK, Kuperman GJ, Rittenberg E, Teich JM, Bates DW. Identifying hospital admissions due to adverse drug events using a computer-based monitor. Pharmacoepidemiol Drug Saf 2001; 10(2): 113-119 (Pubitemid 32590942)
- (2001) Pharmacoepidemiology and Drug Safety , vol.10 , Issue.2 , pp. 113-119
- Jha, A.K.¹ Kuperman, G.J.² Rittenberg, E.³ Teich, J.M.⁴ Bates, D.W.⁵

3
- 84887216371
- Korea Food and Drug Administration (KFDA). KFDA Notice No. 2004-30 (Korean)
- Korea Food and Drug Administration (KFDA). Provision of Safety Information Management Regulation of Drugs. KFDA Notice No. 2004- 30; 2004 (Korean)
- (2004) Provision of Safety Information Management Regulation of Drugs

4
- 84887245433
- Activation of drug adverse event spontaneous reporting
- (Korean)
- Park BJ. Activation of drug adverse event spontaneous reporting. J Korean Med Assoc 2002; 45(11): 1274-1279 (Korean)
- (2002) J Korean Med Assoc , vol.45 , Issue.11 , pp. 1274-1279
- Park, B.J.¹

5
- 0032444841
- Re-examination system for new drugs in Korea
- (Korean)
- Park BJ. Re-examination system for new drugs in Korea. J Korean Soc Clin Pharmacol 1998; 6(1): 3-15 (Korean)
- (1998) J Korean Soc Clin Pharmacol , vol.6 , Issue.1 , pp. 3-15
- Park, B.J.¹

6
- 0030497852
- Regulatory pharmacovigilance in the United Kingdom: Current principles and practice
- DOI 10.1002/(SICI)1099-1557(199611)5:6 <363::AID-PDS249>3.0.CO;2-7
- Waller PC, Coulson RA, Wood SM. Regulatory pharmacovigilance in the United Kingdom: Current principles and practice. Pharmacoepidemiol Drug Saf 1996; 5(6): 363-375 (Pubitemid 27062318)
- (1996) Pharmacoepidemiology and Drug Safety , vol.5 , Issue.6 , pp. 363-375
- Waller, P.C.¹ Coulson, R.A.² Wood, S.M.³

7
- 0037275431
- A model for the future conduct of pharmacovigilance
- DOI 10.1002/pds.773
- Waller PC, Evans SJ. A model for the future conduct of pharmacovigilance. Pharmacoepidemiol Drug Saf 2003; 12(1): 17-29 (Pubitemid 36192946)
- (2003) Pharmacoepidemiology and Drug Safety , vol.12 , Issue.1 , pp. 17-29
- Waller, P.C.¹ Evans, S.J.W.²

8
- 24344486667
- Data mining in pharmacovigilance: The need for a balanced perspective
- DOI 10.2165/00002018-200528100-00001
- Hauben M, Patadia V, Gerrits C, Walsh L, Reich L. Data mining in pharmacovigilance: The need for a balanced perspective. Drug Saf 2005; 28(10): 835-842 (Pubitemid 41428541)
- (2005) Drug Safety , vol.28 , Issue.10 , pp. 835-842
- Hauben, M.¹ Patadia, V.² Gerrits, C.³ Walsh, L.⁴ Reich, L.⁵

9
- 84887243177
- Food and Drug Administration (FDA). Public Law 105-115 [cited 2007 Jun 15]
- Food and Drug Administration (FDA). FDA Moderization Act of 1997. Public Law 105-115 [cited 2007 Jun 15]; Available from: URL:http: //www.fda.gov/cder/ guidance/105-115.htm
- FDA Moderization Act of 1997

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.